selected publications
-
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
The New England journal of medicine.
2018
Academic Article
GET IT
Times cited: 1974 -
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.
Transfusion.
2015
Academic Article
GET IT
Times cited: 9 -
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.
Transfusion.
2015
Academic Article
GET IT
Times cited: 24 -
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Science translational medicine.
2014
Academic Article
GET IT
Times cited: 2084 -
Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy.
International journal of laboratory hematology.
2013
Academic Article
GET IT
Times cited: 6 -
Comparison of automated platelet counts and potential effect on transfusion decisions in cancer patients.
American journal of clinical pathology.
2013
Academic Article
GET IT
Times cited: 6 -
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
Nature genetics.
2013
Academic Article
GET IT
Times cited: 253 -
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Science translational medicine.
2013
Academic Article
GET IT
Times cited: 1723 -
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.
Science translational medicine.
2013
Academic Article
GET IT
Times cited: 156 -
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial.
Cancer.
2012
Academic Article
GET IT
Times cited: 13 -
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis.
Leukemia research.
2012
Academic Article
GET IT
Times cited: 32 -
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood.
2011
Academic Article
GET IT
Times cited: 1123 -
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
Cancer immunology, immunotherapy : CII.
2010
Academic Article
GET IT
Times cited: 111 -
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood.
2010
Academic Article
GET IT
Times cited: 136 -
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2008
Academic Article
GET IT
Times cited: 63 -
Azacitidine and the beginnings of therapeutic epigenetic modulation.
Expert opinion on pharmacotherapy.
2008
Information Resource
GET IT
Times cited: 20 -
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2008
Academic Article
GET IT
Times cited: 120 -
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.
Blood.
2008
Academic Article
GET IT
Times cited: 38 -
Diagnosis and treatment of acute promyelocytic leukemia.
Current oncology reports.
2007
Information Resource
GET IT
Times cited: 34 -
Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2007
Academic Article
GET IT
Times cited: 68 -
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2007
Academic Article
GET IT
Times cited: 288 -
Monoclonal antibody therapy of APL.
Current topics in microbiology and immunology.
2007
Information Resource
GET IT
Times cited: 3 -
Grading follicular lymphomas in fine-needle aspiration biopsies: the role of ThinPrep slides and flow cytometry.
Cancer.
2006
Academic Article
GET IT
Times cited: 18 - Acanthocytes. Blood. 2006 Academic Article GET IT
-
Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?.
Leukemia & lymphoma.
2006
Academic Article
GET IT
Times cited: 10 - Antibody-drug conjugates in acute myeloid leukemia. Nature clinical practice. Oncology. 2006 Academic Article GET IT
-
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 140 -
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome.
Leukemia.
2006
Academic Article
GET IT
Times cited: 99 -
Rhabdomyosarcoma.
Blood.
2005
Academic Article
GET IT
Times cited: 1 -
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 90 -
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Cancer.
2003
Academic Article
GET IT
Times cited: 229 -
Clinical applications of molecular monitoring in leukemia.
Current hematology reports.
2003
Information Resource
GET IT
Times cited: 2 -
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Cancer.
2002
Academic Article
GET IT
Times cited: 25 -
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2002
Academic Article
GET IT
Times cited: 144 -
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol.
Blood.
2001
Academic Article
GET IT
Times cited: 26 -
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2001
Academic Article
GET IT
Times cited: 195 -
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy.
Leukemia.
2000
Academic Article
GET IT
Times cited: 39 -
Targeted therapies for the myeloid leukaemias.
Expert opinion on investigational drugs.
2000
Information Resource
GET IT
Times cited: 12 -
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
The New England journal of medicine.
1998
Academic Article
GET IT
Times cited: 1068 -
The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia.
Seminars in hematology.
1998
Information Resource
GET IT
Times cited: 14 -
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia.
Leukemia.
1998
Academic Article
GET IT
Times cited: 16 -
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1998
Academic Article
GET IT
Times cited: 116 -
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1997
Academic Article
GET IT
Times cited: 117 - Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
-
Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia.
American journal of hematology.
1996
Academic Article
GET IT
Times cited: 9 -
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
Leukemia.
1996
Academic Article
GET IT
Times cited: 22 -
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Journal of the National Cancer Institute.
1995
Academic Article
GET IT
Times cited: 104 -
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
International journal of cancer.
1995
Academic Article
GET IT
Times cited: 93 -
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Leukemia.
1995
Academic Article
GET IT
Times cited: 44 -
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Cytometry.
1994
Academic Article
GET IT
Times cited: 38 -
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
Leukemia.
1994
Academic Article
GET IT
Times cited: 77 -
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1993
Academic Article
GET IT
Times cited: 110 -
CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia.
Blood.
1993
Article
GET IT
Times cited: 17